Page 11 - Haematologica August 2018

haematologica Journal of the European Hematology Association
Published by the Ferrata Storti Foundation
1337 End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
Christopher Melani et al.
1345 Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi
Sergio Storti et al.
1351 A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy
Marek Trne˘ný et al.
Plasma Cell Disorders
1359 Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease Joséphine Muller et al.
1369 Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease Jingsong He et al.
Quality of Life
1380 Meaningful changes in end-of-life care among patients with myeloma Oreofe O. Odejide et al.
Cell Therapy & Immunotherapy
1390 The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation
Alessandra Roberto et al.
Coagulation & Its Disorders
1403 Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms Maria T. Georgescu et al.
Letters to the Editor
Letters are available online only at www.haematologica.org/content/103/8.toc
e331 C/EBPg is dispensable for steady-state and emergency granulopoiesis Miroslava Kardosova et al.
http://www.haematologica.org/content/103/8/e331
e336 GATA1s exerts developmental stage-specific effects in human hematopoiesis Sofia Gialesaki et al.
http://www.haematologica.org/content/103/8/e336
e341 miR-181a regulates erythroid enucleation via the regulation of Xpo7 expression Amalia Avila Figueroa et al.
http://www.haematologica.org/content/103/8/e341
e345 Concurrent treatment of aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience
Morag Griffin et al. http://www.haematologica.org/content/103/8/e345
Haematologica 2018; vol. 103 no. 8 - August 2018 http://www.haematologica.org/